Citation: Id. Horak et al., MANAGEMENT OF HISTOLOGICALLY AGGRESSIVE LYMPHOMAS WITH A HIGH-RISK OFCNS DISEASE, Bailliere's clinical haematology, 9(4), 1996, pp. 707-726
Authors:
SEIDMON EJ
TRUMP DL
KREIS W
HALL SW
KURMAN MR
OUYANG SP
WU J
KREMER AB
Citation: Ej. Seidmon et al., PHASE-I PHASE-II DOSE-ESCALATION STUDY OF LIAROZOLE IN PATIENTS WITH STAGE-D, HORMONE-REFRACTORY CARCINOMA OF THE PROSTATE/, Annals of surgical oncology, 2(6), 1995, pp. 550-556
Authors:
FISCHL MA
RESNICK L
COOMBS R
KREMER AB
POTTAGE JC
FASS SJ
FIFE KH
POWDERLY WG
COLLIER AC
ASPINALL RL
SMITH SL
KOWALSKI KG
WALLEMARK CB
Citation: Ma. Fischl et al., THE SAFETY AND EFFICACY OF COMBINATION N-BUTYL-DEOXYNOJIRIMYCIN (SC-48334) AND ZIDOVUDINE IN PATIENTS WITH HIV-1 INFECTION AND 200-500 CD4 CELLS MM(3)/, Journal of acquired immune deficiency syndromes, 7(2), 1994, pp. 139-147